Premium
Nanobiotechnology: it's a small world after all
Author(s) -
Moos Walter H.,
Barry Stephen
Publication year - 2006
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.20061
Subject(s) - nanobiotechnology , nanotechnology , engineering ethics , drug delivery , engineering , data science , computer science , materials science , nanoparticle
Abstract Nanobiotechnology is the latest technology to provide disruptive—quantum leap—opportunities in drug development research. Examples of the utility of this approach are found increasingly in the scientific literature and the lay press. Whether for therapeutics, diagnostics, drug delivery, targeting, or some other product category, the potential for nanotechnology to revolutionize medicine is quite high. A number of organizations have chosen to focus their nanotechnology efforts on cancer. This is an exciting area that should benefit from an increasing number of collaborations of interdisciplinary experts to fabricate and characterize novel and enabling nanoparticulate technologies. Drug Dev. Res. 67:1–3, 2006.